Results 121 to 130 of about 36,968 (249)

Predictive value of postoperative prognostic nutritional index trajectory for mortality outcomes after off-pump coronary artery bypass surgery: a retrospective cohort study

open access: yesFrontiers in Nutrition
BackgroundThe prognostic nutritional index (PNI) has been widely used as a nutritional metric in patients undergoing cardiac surgery because of its ability to incorporate both nutritional and inflammatory statuses. However, while preoperative PNI is well-
Myung Il Bae   +7 more
doaj   +1 more source

Percutaneous peripheral nerve stimulation as an ancillary treatment following nerve repair surgery

open access: yesPM&R, EarlyView.
Abstract Background Neuropathic pain after peripheral nerve injury severely degrades quality of life. Peripheral nerve stimulation (PN‐Stim) is cleared by the U.S, Food and Drug Administration for the treatment of acute and chronic pain. This broad indication supports its potential use at the time of peripheral nerve repair in patients reporting ...
Shyam Maisuria   +4 more
wiley   +1 more source

Recompensation of Cirrhosis: A New Treatment‐Related Disease State

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
This perspective article conceptualizes recompensation of cirrhosis as a distinct treatment‐related disease state rather than mere transient clinical improvement after etiology‐directed therapy, and further proposes a four‐state classification including compensated cirrhosis, stable recompensation, unstable recompensation, and persistent decompensation
Wentao Tan   +5 more
wiley   +1 more source

The efficacy of concurrent chemoradiotherapy with or without nimotuzumab in high‐risk patients with locally advanced head and neck squamous cell carcinoma post‐surgery: A real‐world study

open access: yesPrecision Radiation Oncology, EarlyView.
Figure 1 Patient selection flowchart. CCRT, concurrent chemoradiotherapy; NCCRT, nimotuzumab and concurrent chemoradiotherapy. Abstract Purpose Patients with locally advanced head and neck squamous cell carcinoma (LA‐HNSCC) harboring high‐risk pathological features after radical surgery face high recurrence rates.
Yuejia Zhou   +8 more
wiley   +1 more source

Methomyl resistance in Dalbulus maidis (Hemiptera: Cicadellidae): selection, inheritance and multiple‐resistance

open access: yesPest Management Science, EarlyView.
The inheritance of methomyl resistance in Dalbulus maidis is autosomal, incompletely dominant and polygenic. No cross‐resistance was found between methomyl and chlorfenapyr, cyantraniliprole and isocycloseram. Abstract BACKGROUND Acetylcholinesterase (AChE) inhibitor insecticides have been important tools for the management of Dalbulus maidis in Brazil;
Matheus Gerage Sacilotto   +3 more
wiley   +1 more source

Current Advances of Treatments, Therapeutic Targets, Biomarkers, Novel Drugs, and Machine Learning for Hypopharyngeal Squamous Cell Carcinoma

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Hypopharyngeal squamous cell carcinoma (HSCC) is an aggressive subtype of head and neck squamous cell carcinoma with insidious onset, early metastasis, and dismal prognosis. Conventional multimodal therapy achieves limited survival benefit, highlighting an urgent need for refined precision strategies.
Ce Li   +12 more
wiley   +1 more source

A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)

open access: yes, 2012
Background: There is increasing evidence that the presence of an ongoing systemic inflammatory response is a stage-independent predictor of poor outcome in patients with cancer.
B V North   +5 more
core   +1 more source

ALBI‐6—A Novel Prognostic Score Combining ALBI and Interleukin‐6 in Patients With HCC Treated With Atezolizumab and Bevacizumab

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
ALBI‐6, a novel score combining albumin–bilirubin grade and interleukin‐6, showed improved prognostic discrimination compared with established scores in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab, supporting its potential use for risk stratification in this setting.
Paula Bark   +31 more
wiley   +1 more source

Cancer pain: current practice and emerging targets

open access: yesBritish Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye   +5 more
wiley   +1 more source

The role of prognostic nutrition index in the prognosis of patients with advanced hepatocellular carcinoma who received first-line therapy

open access: yesBMC Cancer
Objective To explore the relationship between the prognostic nutritional index (PNI) and the anti-tumor efficacy and prognosis of patients with advanced hepatocellular carcinoma (HCC) who received first-line therapy.
Jianwei Liu   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy